Study into conolidine has resulted in discovery of an opioid receptor in the human body named ACKR3/CXCR7. ACKR3 appears to be essentially the most popular target for conolidine, which also disregards another 4 classical opioid receptors(3). Sign in as being a member to find out when there is clinical https://michelangelou593pxg7.nizarblog.com/profile